<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare the efficacy of unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> and low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> in the in vitro binding of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> obtained from the sera of patients with recurrent pregnancy loss </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Women with immunoglobulin (Ig) G antibodies to the <z:chebi fb="1" ids="16247">phospholipids</z:chebi> <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> and phosphatidylserine were selected based on a positive test by a standard enzyme-linked immunosorbent assay (ELISA) </plain></SENT>
<SENT sid="2" pm="."><plain>The sera were reassayed for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in a modified ELISA using increasing doses of unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> or low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> (0, 16, 32, 64, 128, and 256 IU) </plain></SENT>
<SENT sid="3" pm="."><plain>Sera were fractionated by unfractionated and low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> affinity chromatography to compare the binding avidity and <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> activity </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> sera demonstrated a dose-dependent inhibition in measured <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> activity with the addition of unfractionated or low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Levels of IgG <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> and IgG phosphatidylserine were significantly inhibited in the presence of 32 IU of low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> (P &lt;.001 and P &lt;.05, respectively) and in the presence of 64 IU of unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> (P &lt;.001 and P &lt;.05, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> binding activity in serum as measured in the ELISA was maximally reduced 76-89% with 256 IU of either <z:chebi fb="5" ids="28304">heparin</z:chebi> derivative </plain></SENT>
<SENT sid="7" pm="."><plain>Affinity chromatography with unfractionated or low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> columns absorbed 72% and 66% of IgG <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> activity, respectively, and 46% and 54% of IgG phosphatidylserine activity, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: These data suggest that low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> and unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> reduce the in vitro binding of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> on a per unit basis </plain></SENT>
<SENT sid="9" pm="."><plain>Both <z:chebi fb="0" ids="24505">heparins</z:chebi> demonstrate binding activity similar to that of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in vitro </plain></SENT>
</text></document>